These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36193976)

  • 1. Intestinal homeostasis in autoimmune liver diseases.
    Liu Q; He W; Tang R; Ma X
    Chin Med J (Engl); 2022 Jul; 135(14):1642-1652. PubMed ID: 36193976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of gut microbiota in autoimmune liver diseases.
    Qian Q; He W; Tang R; Ma X
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.
    Liwinski T; Heinemann M; Schramm C
    Semin Immunopathol; 2022 Jul; 44(4):485-507. PubMed ID: 35536431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG4-related autoimmune liver disease.
    Capurso G; Pedica F; Palumbo D; Della-Torre E
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):23-49. PubMed ID: 33267565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.
    Richardson N; Wootton GE; Bozward AG; Oo YH
    Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
    Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
    World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review.
    Liu SP; Bian ZH; Zhao ZB; Wang J; Zhang W; Leung PSC; Li L; Lian ZX
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):252-271. PubMed ID: 32076943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
    Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G4-related hepatobiliary disease.
    Lee HE; Zhang L
    Semin Diagn Pathol; 2019 Nov; 36(6):423-433. PubMed ID: 31358425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances in autoimmune liver diseases in 2016].
    Li B; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):100-104. PubMed ID: 28297794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges.
    He C; Yang Y; Zheng K; Chen Y; Liu S; Li Y; Han Q; Zhao RC; Wang L; Zhang F
    Ther Adv Chronic Dis; 2021; 12():2040622321993442. PubMed ID: 33633826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.
    Sun C; Zhu D; Zhu Q; He Z; Lou Y; Chen D
    Front Cell Infect Microbiol; 2024; 14():1337223. PubMed ID: 38404291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
    Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two decades of research on autoimmune liver disease in Turkey.
    Demir N; Ekin N; Torgutalp M; Wahlin S; Efe C
    Turk J Gastroenterol; 2020 Dec; 31(12):877-882. PubMed ID: 33626000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Dry Copper Weight in Pediatric Autoimmune Liver Disease.
    Nayagam JS; Joshi D; Thompson RJ; Dhawan A; Hadzic N; Mestre-Alagarda C; Deheragoda M; Samyn M
    J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):e21-e26. PubMed ID: 36332083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary features in liver histology of children with autoimmune liver disease.
    Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
    Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA, gut microbiome and hepatic autoimmunity.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    Front Immunol; 2022; 13():980768. PubMed ID: 36059527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.